A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts

被引:2
|
作者
Escudero-Ferruz, Paula [1 ,2 ]
Ontiveros, Neus [1 ,2 ]
Cano-Estrada, Claudia [1 ,2 ]
Sutcliffe, Diane J. [3 ]
Jinnah, H. A. [3 ,4 ,5 ]
Torres, Rosa J. [6 ,7 ]
Lopez, Jose M. [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Inst Neurociencies, Cerdanyola Del Valles 08193, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim, Fac Med, Cerdanyola Del Valles 08193, Barcelona, Spain
[3] Emory Univ, Dept Neurol, Sch Med, 101 Woodruff Circle,6305 Woodruff Mem Bldg, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA
[5] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA
[6] Inst Salud Carlos III ISCIII, Ctr Biomed Network Res Rare Dis, Madrid 28029, Spain
[7] La Paz Univ Hosp Hlth Res Inst, Dept Biochem, IdiPaz, Madrid 28046, Spain
关键词
Purine nucleotides; Folic acid; Lesch-Nyhan disease; ZMP; AICAR; Plasmax; ACTIVATED PROTEIN-KINASE; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; METABOLISM; BIOSYNTHESIS;
D O I
10.1186/s10020-023-00774-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundLesch-Nyhan disease (LND) is a severe neurological disorder caused by the genetic deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGprt), an enzyme involved in the salvage synthesis of purines. To compensate this deficiency, there is an acceleration of the de novo purine biosynthetic pathway. Most studies have failed to find any consistent abnormalities of purine nucleotides in cultured cells obtained from the patients. Recently, it has been shown that 5-aminoimidazole-4-carboxamide riboside 5MODIFIER LETTER PRIME-monophosphate (ZMP), an intermediate of the de novo pathway, accumulates in LND fibroblasts maintained with RPMI containing physiological levels (25 nM) of folic acid (FA), which strongly differs from FA levels of regular cell culture media (2200 nM). However, RPMI and other standard media contain non-physiological levels of many nutrients, having a great impact in cell metabolism that does not precisely recapitulate the in vivo behavior of cells.MethodsWe prepared a new culture medium containing physiological levels of all nutrients, including vitamins (Plasmax-PV), to study the potential alterations of LND fibroblasts that may have been masked by the usage of non-physiological media. We quantified ZMP accumulation under different culture conditions and evaluated the activity of two known ZMP-target proteins (AMPK and ADSL), the mRNA expression of the folate carrier SLC19A1, possible mitochondrial alterations and functional consequences in LND fibroblasts.ResultsLND fibroblasts maintained with Plasmax-PV show metabolic adaptations such a higher glycolytic capacity, increased expression of the folate carrier SCL19A1, and functional alterations such a decreased mitochondrial potential and reduced cell migration compared to controls. These alterations can be reverted with high levels of folic acid, suggesting that folic acid supplements might be a potential treatment for LND.ConclusionsA complete physiological cell culture medium reveals new alterations in Lesch-Nyhan disease. This work emphasizes the importance of using physiological cell culture conditions when studying a metabolic disorder.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts
    Paula Escudero-Ferruz
    Neus Ontiveros
    Claudia Cano-Estrada
    Diane J. Sutcliffe
    H. A. Jinnah
    Rosa J. Torres
    José M. López
    Molecular Medicine, 30
  • [2] Physiological levels of folic acid reveal purine alterations in Lesch-Nyhan disease
    Lopez, Jose M.
    Outtrim, Esther L.
    Fu, Rong
    Sutcliffe, Diane J.
    Torres, Rosa J.
    Jinnah, H. A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (22) : 12071 - 12079
  • [3] Lesch-Nyhan disease
    Nyhan, W. L.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2008, 27 (6-7): : 559 - 563
  • [4] Metabolic alterations in Lesch-Nyhan syndrome
    Burhenne, H.
    Tschirner, S.
    Kuhn, M.
    Kaever, A.
    Seifert, R.
    Kaever, V.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S14 - S14
  • [5] NEW APPROACH IN TREATMENT OF LESCH-NYHAN DISEASE
    GHADIMI, H
    PEDIATRIC RESEARCH, 1970, 4 (02) : 204 - &
  • [6] New approaches to understanding Lesch-Nyhan disease
    Nyhan, WL
    Wong, DF
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (24): : 1602 - 1604
  • [7] LESCH-NYHAN DISEASE - STUDY OF A NEW PATIENT
    CARMENA, R
    NYHAN, WL
    ASCASO, J
    BAKAY, B
    SORIANO, J
    TEBAR, J
    MEDICINA CLINICA, 1982, 78 (02): : 59 - 64
  • [8] Sudden death in Lesch-Nyhan disease
    Neychev, Vladimir Kostadinov
    Jinnah, H. A.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (11): : 923 - 926
  • [9] Prenatal diagnosis of Lesch-Nyhan disease
    Nyhan, WL
    Vuong, LUC
    Broock, R
    PRENATAL DIAGNOSIS, 2003, 23 (10) : 807 - 809
  • [10] CLINICAL AND BIOCHEMICAL HETEROGENEITY OF THE LESCH-NYHAN SYNDROME
    SHAPOSHNIKOV, AM
    ALEKSANDROVA, LA
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1979, 79 (10): : 1379 - 1385